Focusing first onAngptl7,wefindthatprior
RNA sequencing (RNA-seq) data ( 28 )showed
thatAngptl7was not even expressed in the
primed HG cells of telogen or early anagen
HFs (Fig. 4C and fig. S8D). To delineate the
detailed temporal changes ofAngptl7within
bulgeSCs,weperformedstage-specific single-
cell RNA-seq. Three distinct temporal patterns
emerged from t-distributed stochastic neigh-
bor embedding (t-SNE) and unsupervised hier-
archical clustering (Fig. 4D and fig. S8E). Using
machine learning–based cell-cycle allocation
analysis ( 29 ), it was concluded that prolifer-
ative cells resided in AnaII SCs, in agreement
with our 5-ethynyl-2′-deoxyuridine (EdU) label-
ing studies. Additionally, in contrast to SC
markerSox9, which was maintained in bulge
SCs at all stages,Angptl7transcription in bulge
SCs diminished shortly after anagen onset,
even sooner than that of established quiescence
regulatorNfatc1( 28 ). Moreover, theAngptl7
expression dip was transient, occurring only
between AnaII and AnaIII (Fig. 4E).
Angptl7dynamics were recapitulated at the
chromatin level. As judged by chromatin immu-
noprecipitation sequencing (ChIP-seq) analyses
of fluorescence-activated cell sorting (FACS)–
purified HF cells ( 30 ), theAngptl7chroma-
tin state was active in telogen (H3K27ac+),
poised in AnaIII (H3K27acnegH3K4me1+),
and silent in AnaVI differentiated cells
(H3K27acnegH3K4me1neg) (fig. S9A). More-
over, when either of the twoAngptl7locus–
accessible chromatin elements ( 30 )wereused
as enhancers to drive enhanced green fluores-
cent protein (eGFP) expression in vivo, report-
ers faithfully recapitulatedAngptl7’s temporal
dynamics in bulge expression during the hair
cycle (Fig. 4F and fig. S9B). These results
intimated that changes in SC-derivedAngptl7
transcription are involved in reshaping the
regenerative microenvironment of the niche.
Gur-Cohenet al.,Science 366 , 1218–1225 (2019) 6 December 2019 3of8
Prox1-CreER+ ; iDTRfl
TAM
TAMTAMTAMDT Analysis
2 nd
Telogen
P60 (Day 0)
Full Ana
P15
Day 1-10
x1x1 Crx1 Cr-Cr
AM
CrreEERRR++;iiDTRRRfl
TTTA
TTTA
rreErER;iiDTR
A
TTTA
reEERR; iDTRi
AMAM
AMDTT Analysis
LYVE1 pattern
Prox1-CreER+;iDTRfl
Ctrl depleted (D10)
Ctrl
Targeted lymphatic vessel depletion
LYVE1 LYVE1
Prox1-CreER+;iDTR-depleted (D10)
HFs precociously enter anagen upon lymphatic vessel depletion
50 μm
DAPI P-CAD SOX9 LYVE1
30 μm
SCs exit quiescence upon depletion
Ctrl
Prox1-
depleted
0
20
40
60
80
100
120
%
Hair follicles
Tel-Ana I
Ana II-III
Ana IV-V
P < 0.0001
P = 0.0347
P = 0.0013
DyeCycle Violet
Day 1 post depletion
S/M/G2
G0/G1
A
0.0
0.5
1.0
1.5
2.0
2.5
Lymphatic capillar
ies volume
(per 1
μm
3 area)
p = 0.0183
Ctrl
Prox1-
depleted
0
500
1000
1500
2000
LYVE1 intensity(per μm
3 ; a.u.)
p = 0.0232
Ctrl
Prox1-
depleted
IgG Ctrl
VEGFR3-Fc
0
10
20
30
40
50
EdU
+ cell
s per folli
cle
IgG Ctrl p < 0.0001
VEGFR3-Fc
KRT24 P-CAD EdU DAPI30 μm 30 μm 30 μm
IgG/VR3-Fc Analysis
2 nd
Telogen
(P60)
IgG/VR3-FcIgG/VR3-FcIgG/VR3-Fc
P65
IgG/VR3-Fc
Lymphatic regression upon disruption of VEGFR3 signaling induces anagen entry
IgG Ctrl
VEGFR3-Fc
0
20
40
60
80
100
120
% Hair follicles
Telogen-Ana I
P < 0.0001
P < 0.0001
P = 0.9036
Ana II-III
A Ana IV-V
-Fc
IgIgG/VRIg Ig IgG/VR3-FIgGG/VR/
3-F
c
IgG
/VR3-F
c
IgG
/VR3-Fc
IgG
/VR3-
IgG/
IgG/VEGFR3-Fc
ID injection
B C
D
Ctrl
Depleted D1
0
20
40
60
80
100
120
Cell cycle profile in HFSCs
G0/G1
S/M/G2
p = 0.0045
p = 0.0051
+DT
ID injection
Ctrl
Depleted
0
20
40
60
80
100
-10^30103104105
Fig. 2. Disrupting lymphatic capillaries triggers hair regeneration.
(A) Timeline of experimental model and diphtheria toxin (DT)–induced
depletion of lymphatic vessels during the long quiescence of second telogen.
Quantifications: lymphatic intensity (n= 3); volume (n=5and4forCtrl
andProx1-depleted, respectively; two-tailed unpairedttest). ID, intradermal;
TAM, tamoxifen; P, postnatal day; Ctrl, control; D, day; a.u., arbitrary units.
(B) Precocious anagen induction after lymphatic depletion, as demonstrated
by HF growth and association with LYVE1+capillaries (n= 5, two-way ANOVA
with Sidak’s multiple comparisons test). P-CAD, P-cadherin. (C) Flow cytometry
of HFSC cell cycle after lymphatic depletion (n= 3, two-way ANOVA with Sidak’s
multiple comparisons test). (D) Experimental strategy using decoy VEGF3-Fc to
interrupt VEGFR3 signaling in dermal lymphatic vessels. EdU incorporation reveals
anagen entry after treatment (n= 4, multiple EdU measurements, two-tailed
unpairedttest). IgG, immunoglobulin G.
RESEARCH | RESEARCH ARTICLE
on December 12, 2019^
http://science.sciencemag.org/
Downloaded from